|
PXL/HO/Cir-086/2019-20 Dt: 05.12.2019
Hyderabad
Dear Sir/Madam,
Subject: Executive Training on Drug Development and Regulatory Affairs during 7-8th Dec.2019 at Dr.Reddy’s Institute of Life Sciences at University of Hyderabad Campus.
We would like to inform member companies that Manipal Academy of Higher Education (MAHE) in collaboration with European Centre of Pharmaceutical Medicine (ECPM), University of Basel, Switzerland with support from Dr.Reddy’s Institute of Life Sciences(DRILS), Hyderabad is organising a two-day Executive Training on “Drug Development and Regulatory Affairs” during 7-8th Dec.2019.
The European Centre of Pharmaceutical Medicine (ECPM) is the leading university institute for medicines and drug development in Europe. Experts representing the European Centre of Pharmaceutical Medicine and the University of Basel will be conducting a two-day session and their goal is to provide information about the process of drug development and the regulatory landscape, especially in the context of Europe. The expert faculty include
· Prof Dr.Helmut Brand, Director, Jean Monnet Professor of European Public Health and Head of
· the Department of International Health at Maastricht University, Netherlands
· Dr.Annette Mollet, Managing Director of European Centre of Pharmaceutical Medicine (ECPM)
· Dr.Lada Leyens, Head of the Centre of Regulatory Affairs MAHE and Regulatory Manager,
· European Program Lead at Roche, Basel, Switzerland.
The information of modules covered during the programme are as follows:
|
Module 1
|
Global Drug Research & Development and the Pharmaceutical Business Environment
|
|
Module 2
|
Finding a New Drug and the Transition from Animal into Human Body
|
|
Module 3
|
Safety Concepts & Personalised Treatment
|
|
Module 4
|
Clinical Trials and Data Management
|
|
Module 5
|
Global Registration and Market Access
|
|
Module 6
|
Trends and Innovative Tools
|
Who can attend: The programme is designed for Regulatory, Clinical and Drug Development professionals.
Registration:DRILS have requested Pharmexcil to nominate 20 delegates as complimentary registration. Each company can nominate one delegate for this programme. Member companies interested in registering the programme are requested to email at kiranamc@drils.org. Registration confirmation is done by the DRILS and is based on first-cum-first serve basis.
With regards,
Uday Bhaskar
Director General
| 
